Jay W. Carlson

Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study

William E. Winter, G. Larry Maxwell, Chunqiao Tian et al. · Journal of Clinical Oncology · 2007 · 839 citations · Full text

A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer

Carol Aghajanian, Virginia L. Filiaci, Don S. Dizon et al. · Gynecologic Oncology · 2018 · 138 citations

Frontline Paclitaxel/carboplatin/bevacizumab, Medicine, Gynecology +8

GOG 244-The lymphedema and gynecologic cancer (LEG) study: Incidence and risk factors in newly diagnosed patients

Jay W. Carlson, James Kauderer, Alan D. Hutson et al. · Gynecologic Oncology · 2019 · 123 citations · Full text

Lymphoid Neoplasia, Medicine, Gynecology +6

A randomized phase III trial of VH fibrin sealant to reduce lymphedema after inguinal lymph node dissection: A Gynecologic Oncology Group study

Jay W. Carlson, James Kauderer, Joan L. Walker et al. · Gynecologic Oncology · 2008 · 108 citations

Gynecologic Surgery, Surgical Oncology, Gynecological Surgery +6

Lymph Node Yield from Laparoscopic Lymphadenectomy in Cervical Cancer: A Comparative Study

Jeffrey M. Fowler, Jonathan Carter, Jay W. Carlson et al. · Gynecologic Oncology · 1993 · 102 citations

Surgical Oncology, Gynecological Surgery, Cervical Cancer +6